What they were paid
Nuvalent Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $2,511 | $299,984 | $299,957 | — | $602,452 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Nuvalent, Inc. DEF 14A filed April 28, 2026, accession 0001861560-26-000013, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Nuvalent pays directors $425,000 in equity.
Committees
FY2025 · as the proxy prints themNominating/Governance
The rest of the Nuvalent board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Anna Protopapas | Independent Director | $485,432 |
| Cameron A. Wheeler, Ph.D | Independent Director | $454,762 |
| Christy Oliger | Independent Director | $627,666 |
| Grant C. Bogle | Independent Director | $449,927 |
| James R. Porter, Ph.D | Director | $0 |
| Joseph Pearlberg, M.D., Ph.D | Independent Director | $446,932 |
| Michael L. Meyers, M.D., Ph.D | Independent Director | $451,932 |
| Sapna Srivastava, Ph.D | Independent Director | $461,932 |
The full Nuvalent compensation record
free company briefThis page is one director within Nuvalent's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat